Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$13.76 USD
+0.13 (0.95%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $13.78 +0.02 (0.15%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.22 | 0.00% |
Earnings Summary
For their last quarter, Day One Biopharmaceuticals (DAWN) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.67 per share. This reflects a positive earnings surprise of 92.54%. Look out for DAWN's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year increase of 59.26%.
Earnings History
Price & Consensus
Zacks News for DAWN
Day One (DAWN) In-Licenses MabCare Cancer Candidate, Stock Up
DAWN: What are Zacks experts saying now?
Zacks Private Portfolio Services